Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease

Physiological Reports

Volumn 4, Issue 9, 2016, Pages 1-12

  Gamboa, Jorge L ^a   Billings, Frederic T ^a   Bojanowski, Matthew T ^a   Gilliam, Laura A ^b   Yu, Chang ^a   Roshanravan, Baback ^c   Roberts, L Jackson ^a   Himmelfarb, Jonathan ^c   Ikizler, T Alp ^a   Brown, Nancy J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

BNIP3; Chronic kidney disease; Mitochondria; Mitochondrial DNA copy number; Oxidative stress; PGC1 ; Skeletal muscle

Indexed keywords

ADULT; ANIMAL; C57BL MOUSE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRION; MOUSE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SKELETAL MUSCLE;

ADULT; ANIMALS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84968750606     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12780     Document Type: Article

References (48)

1. Adey, D., R. Kumar, J. T. McCarthy, and K. S. Nair . 2000. Reduced synthesis of muscle proteins in chronic renal failure. Am. J. Physiol. Endocrinol. Metab. 278:E219-E225.
2. Ahonen, R. E. 1980. Striated muscle ultrastructure in uremic patients and in renal transplant recipients. Acta Neuropathol. 50:163-166.
3. Ballinger, S. W., C. Patterson, C. A. Knight-Lozano, D. L. Burow, C. A. Conklin, Z. Hu, et al. 2002. Mitochondrial integrity and function in Atherogenesis. Circulation 106:544-549.
4. Bao, Y., L. Dalrymple, G. M. Chertow, G. A. Kaysen, and K. L. Johansen . 2012. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch. Intern. Med. 172:1071-1077.
5. Baron, A. D., G. Brechtel-Hook, A. Johnson, and D. Hardin . 1993. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 21:129-135.
6. Berthiaume, J. M., and K. B. Wallace . 2007. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol. Toxicol. 23:15-25.
7. Broskey, N. T. D. 2013. Skeletal muscle mitochondrial and lipid droplet content assessed with standardized grid sizes for stereology. J. Appl. Physiol. 115:765-770.
8. Conjard, A., B. Ferrier, M. Martin, A. Caillette, H. Carrier, and G. Baverel . 1995. Effects of chronic renal failure on enzymes of energy metabolism in individual human muscle fibers. J. Am. Soc. Nephrol. 6:68-74.
9. Cooper, C., W. Dere, W. Evans, J. A. Kanis, R. Rizzoli, A. A. Sayer, et al. 2012. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos. Int. 23:1839-1848.
10. Crawford, S. O., M. S. Ambrose, R. C. Hoogeveen, F. L. Brancati, C. M. Ballantyne, and J. H. Young . 2008. Association of lactate with blood pressure before and after rapid weight loss. Am. J. Hypertens. 21:1337-1342.
11. Croteau, D. L., and V. A. Bohr . 1997. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J. Biol. Chem. 272:25409-25412.
12. Diesel, W., B. K. Knight, T. D. Noakes, C. R. Swanepoel, van Zyl Smit R., R. O. C. Kaschula, et al. 1993. Morphologic features of the myopathy associated with chronic renal failure. Am. J. Kidney Dis. 22:677-684.
13. DiGirolamo, M., F. D. Newby, and J. Lovejoy . 1992. Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J. 6:2405-2412.
14. Durozard, D., P. Pimmel, S. Baretto, A. Caillette, M. Labeeuw, G. Baverel, et al. 1993. 31P NMR spectroscopy investigation of muscle metabolism in hemodialysis patients. Kidney Int. 43:885-892.
15. Fessel, J. P., N. A. Porter, K. P. Moore, J. R. Sheller, and L. J. Roberts . 2002. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc. Natl Acad. Sci. U. S. A. 99:16713-16718.
16. Fessel, J. P., C. Hulette, S. Powell, L. J. Roberts, and J. Zhang . 2003. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease. J. Neurochem. 85:645-650.
17. Fliss, M. S., H. Usadel, O. L. Caballero, L. Wu, M. R. Buta, S. M. Eleff, et al. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019.
18. Foley, R. N., P. S. Parfrey, and M. J. Sarnak . 1998. Epidemiology of cardiovascular disease in chronic renal disease. J. Am. Soc. Nephrol. 9:S16-S23.
19. Gamboa, J. L., and F. H. Andrade . 2012. Muscle endurance and mitochondrial function after chronic normobaric hypoxia: contrast of respiratory and limb muscles. Pflugers Arch. 463:327-338.
20. Gilliam, L. A. A., K. H. Fisher-Wellman, C. T. Lin, J. M. Maples, B. L. Cathey, and P. D. Neufer . 2013. The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle. Free Radic. Biol. Med. 65:988-996.
21. Go, A. S., G. M. Chertow, D. Fan, C. E. McCulloch, and C. Y. Hsu . 2004. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351:1296-1305.
22. Granata, S., G. Zaza, S. Simone, G. Villani, D. Latorre, P. Pontrelli, et al. 2009. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genom. 10:388.
23. Himmelfarb, J., P. Stenvinkel, T. A. Ikizler, and R. M. Hakim . 2002. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 62:1524-1538.
24. Ide, T., H. Tsutsui, S. Hayashidani, D. Kang, N. Suematsu, K. Nakamura, et al. 2001. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 88:529-535.
25. Isoyama, N., A. R. Qureshi, C. M. Avesani, B. Lindholm, P. Bàràny, O. Heimbürger, et al. 2014. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin. J. Am. Soc. Nephrol. 9:1720-1728.
26. Kadiiska, M. B., B. C. Gladen, D. D. Baird, D. Germolec, L. B. Graham, C. E. Parker, et al. 2005. Biomarkers of Oxidative Stress Study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic. Biol. Med. 38:698-710.
27. Kemp, G. J., A. V. Crowe, H. K. I. Anijeet, Q. Y. Gong, W. E. Bimson, S. P. Frostick, et al. 2004. Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo. Nephrol. Dial. Transplant. 19:1520-1527.
28. Lewis, M. I., M. Fournier, H. Wang, T. W. Storer, R. Casaburi, A. H. Cohen, et al. 2012. Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients. J. Appl. Physiol. 112:72-78.
29. López-Armada, M. J., R. R. Riveiro-Naveira, C. Vaamonde-García, and M. N. Valcárcel-Ares . 2013. Mitochondrial dysfunction and the inflammatory response. Mitochondrion 13:106-118.
30. Madamanchi, N. R., and M. S. Runge . 2007. Mitochondrial dysfunction in Atherosclerosis. Circ. Res. 100:460-473.
31. Malik, A. N., and A. Czajka . 2013. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion 13:481-492.
32. Matsushita, K., E. K. Williams, M. L. Mongraw-Chaffin, J. Coresh, M. I. Schmidt, F. L. Brancati, et al. 2013. The association of plasma lactate with incident cardiovascular outcomes: the ARIC study. Am. J. Epidemiol. 178:401-409.
33. Milne, G. L., S. C. Sanchez, E. S. Musiek, and J. D. Morrow . 2007. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc. 2:221-226.
34. Morley, J. E., B. Vellas, van Kan G. A., S. D. Anker, J. M. Bauer, R. Bernabei, et al. 2013. Frailty consensus: a call to action. J. Am. Med. Dir. Assoc. 14:392-397.
35. Morrow, J. D., K. E. Hill, R. F. Burk, T. M. Nammour, K. F. Badr, and L. J. Roberts . 1990. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl Acad. Sci. U. S. A. 87:9383-9387.
36. O'Leary, M. F., A. Vainshtein, S. Iqbal, O. Ostojic, and D. A. Hood . 2013. Adaptive plasticity of autophagic proteins to denervation in aging skeletal muscle. Am. J. Physiol. Cell Physiol. 304:C422-C430.
37. Pastoris, O., R. Aquilani, P. Foppa, G. Bovio, S. Segagni, P. Baiardi, et al. 1997. Altered muscle energy metabolism in post-absorptive patients with chronic renal failure. Scand. J. Urol. Nephrol. 31:281-287.
38. Rao, M., L. Li, C. Demello, D. Guo, B. L. Jaber, B. J. G. Pereira, et al. and the HEMO Study Group. 2009. Mitochondrial DNA injury and mortality in hemodialysis patients. J. Am. Soc. Nephrol. 20:189-196.
39. Sarnak, M. J., and A. S. Levey . 1999. Epidemiology of cardiac disease in dialysis patients. Semin. Dial. 12:69-76.
40. Shah, A. J., V. Sahgal, A. P. Quintanilla, V. Subramani, H. Singh, and R. Hughes . 1983. Muscle in chronic uremia-a histochemical and morphometric study of human quadriceps muscle biopsies. Clin. Neuropathol. 2:83-89.
41. Tamaki, M., K. Miyashita, S. Wakino, M. Mitsuishi, K. Hayashi, and H. Itoh . 2014. Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase. Kidney Int. 85:1330-1339.
42. Terman, A., B. Gustafsson, and U. T. Brunk . 2006. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem. Biol. Interact. 163:29-37.
43. Terman, A., T. Kurz, M. Navratil, E. A. Arriaga, and U. T. Brunk . 2009. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 12:503-535.
44. Thompson, C. H., G. J. Kemp, D. J. Taylor, J. G. G. Ledingham, G. K. Radda, and B. Rajagopalan . 1993. Effect of chronic uraemia on skeletal muscle metabolism in man. Nephrol. Dial. Transplant. 8:218-222.
45. Yen, H. C., T. D. Oberley, C. G. Gairola, L. I. Szweda, and D. K. St. Clair . 1999. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch. Biochem. Biophys. 362:59-66.
46. Yeung, C. K., F. T. Billings, A. J. Claessens, B. Roshanravan, L. Linke, M. B. Sundell, et al. 2015. Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress. BMC Nephrol. 16:1-8.
47. Zhang, H., M. Bosch-Marce, L. A. Shimoda, Y. S. Tan, J. H. Baek, J. B. Wesley, et al. 2008. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283:10892-10903.
48. Zick, M., R. Rabl, and A. S. Reichert . 2009. Cristae formation-linking ultrastructure and function of mitochondria. Biochim. Biophys. Acta 1793:5-19.